Bellevue Healthcare (BBH) Competitors

JPMorgan Emerging Markets (LON:JMG) and Bellevue Healthcare (LON:BBH) are both small-cap financial services companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, community ranking, dividends, media sentiment and analyst recommendations.

Is JMG or BBH more profitable?

Bellevue Healthcare has a net margin of 169.10% compared to JPMorgan Emerging Markets' net margin of 82.19%. JPMorgan Emerging Markets' return on equity of 6.30% beat Bellevue Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
JPMorgan Emerging Markets	82.19%	6.30%	1.55%
Bellevue Healthcare	169.10%	-4.48%	N/A

Does the MarketBeat Community prefer JMG or BBH?

Bellevue Healthcare received 33 more outperform votes than JPMorgan Emerging Markets when rated by MarketBeat users. However, 75.73% of users gave JPMorgan Emerging Markets an outperform vote while only 68.52% of users gave Bellevue Healthcare an outperform vote.

Company	Underperform	Outperform
JPMorgan Emerging Markets	Outperform Votes 78 75.73%	Underperform Votes 25 24.27%
Bellevue Healthcare	Outperform Votes 111 68.52%	Underperform Votes 51 31.48%

Is JMG or BBH a better dividend stock?

JPMorgan Emerging Markets pays an annual dividend of GBX 2 per share and has a dividend yield of 1.8%. Bellevue Healthcare pays an annual dividend of GBX 6 per share and has a dividend yield of 4.8%. JPMorgan Emerging Markets pays out 26.5% of its earnings in the form of a dividend. Bellevue Healthcare pays out -91.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Bellevue Healthcare is clearly the better dividend stock, given its higher yield and lower payout ratio.

Does the media favor JMG or BBH?

In the previous week, JPMorgan Emerging Markets had 1 more articles in the media than Bellevue Healthcare. MarketBeat recorded 2 mentions for JPMorgan Emerging Markets and 1 mentions for Bellevue Healthcare. JPMorgan Emerging Markets' average media sentiment score of 0.14 beat Bellevue Healthcare's score of 0.00 indicating that JPMorgan Emerging Markets is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
JPMorgan Emerging Markets	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Bellevue Healthcare	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do insiders & institutionals believe in JMG or BBH?

48.5% of JPMorgan Emerging Markets shares are owned by institutional investors. Comparatively, 40.6% of Bellevue Healthcare shares are owned by institutional investors. 1.8% of JPMorgan Emerging Markets shares are owned by insiders. Comparatively, 0.1% of Bellevue Healthcare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Which has better valuation and earnings, JMG or BBH?

JPMorgan Emerging Markets has higher revenue and earnings than Bellevue Healthcare. Bellevue Healthcare is trading at a lower price-to-earnings ratio than JPMorgan Emerging Markets, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
JPMorgan Emerging Markets	£97.45M	12.26	£80.10M	£7.55	14.94
Bellevue Healthcare	-£9.60M	-31.80	-£16.23M	-£6.57	-18.83

Summary

JPMorgan Emerging Markets beats Bellevue Healthcare on 12 of the 16 factors compared between the two stocks.